SCHEMBL4358463

SCHEMBL4358463

CC(C)CCNCc1ccc(Oc2cccc(O)c2)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 1/20 0.47
CARM1 Q86X55 3/20 0.47
PRMT6 Q96LA8 3/20 0.47
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
ADRA1D P25100 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43
DRD3 P35462 1/20 0.43
MAPT P10636 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
OPRK1 P41145 1/20 0.38
CD274 Q9NZQ7 1/20 0.38
MITF O75030 1/20 0.38
BCHE P06276 1/20 0.37
HTR2A P28223 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4017085 0.87 NPSR1 (0.49) PPARDCARM1PRMT6MAPTNPSR1
SCHEMBL4018970 0.81 CARM1 (0.42) PPARDCARM1PRMT6MAPTNPSR1
SCHEMBL11990073 0.78 PPARD (0.43) PPARD
SCHEMBL4020149 0.74 CARM1 (0.41) PPARDCARM1PRMT6MAPTNPSR1
SCHEMBL13773070 0.74 OPRM1 (0.52) PPARDCARM1PRMT6MAPTNPSR1
SCHEMBL13632816 0.74 CARM1 (0.40) PPARDCARM1PRMT6MAPTNPSR1
SCHEMBL3694628 0.73 OPRK1 (0.49) MAPTNPSR1MAPK1L3MBTL1OPRK1
SCHEMBL13285432 0.73 OPRM1 (0.45) CARM1PRMT6MAPTNPSR1MAPK1
SCHEMBL8546474 0.72 PPARD (0.47) PPARDCARM1PRMT6MEN1KMT2A
SCHEMBL3693715 0.71 OPRM1 (0.48) PPARDCARM1PRMT6MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618996-B2 Diaryl ether derivatives and uses thereof PFIZER INC. (US) 2009-11-17 US disclosed
US-7618996-B2 Diaryl ether derivatives and uses thereof PFIZER INC. (US) 2009-11-17 US disclosed
US-7618996-B2 Diaryl ether derivatives and uses thereof PFIZER INC. (US) 2009-11-17 US disclosed
US-20080070887-A1 Diaryl Ether Derivatives and Uses Thereof PFIZER INC 2008-03-20 US disclosed
US-20080070887-A1 Diaryl Ether Derivatives and Uses Thereof PFIZER INC 2008-03-20 US disclosed
US-20080070887-A1 Diaryl Ether Derivatives and Uses Thereof PFIZER INC 2008-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070887-A1 Diaryl Ether Derivatives and Uses Thereof OPRD1, OPRK1, OPRL1 PPARD 230/4885CARM1 960/4885PRMT6 663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.